Ruiyun Guo

Title: Ruiyun Guo: Innovator in Tyrosine Kinase Inhibition

Introduction

Ruiyun Guo is a prominent inventor based in Zhengzhou, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds for medical applications. His work focuses on creating effective inhibitors for critical biological processes.

Latest Patents

Ruiyun Guo holds a patent for "Bis-quinazoline derivatives as inhibitors for epidermal growth factor receptor (EGFR) tyrosine kinase." This invention discloses novel bis-quinazoline derivatives that serve as tyrosine kinase inhibitors. The patent details the synthesis of these compounds and outlines innovative methods for treating diseases or disorders mediated by tyrosine kinase. Specifically, the invention provides tethered quinazoline derivative dimers as inhibitors to the EGFR tyrosine kinase. It also includes pharmaceutical compositions and therapeutic uses for treating EGFR kinase-mediated diseases, such as various cancers.

Career Highlights

Ruiyun Guo has established himself as a key figure in his field through his innovative research and development efforts. His work has the potential to impact the treatment of serious medical conditions, particularly cancer, by providing new therapeutic options.

Collaborations

Ruiyun collaborates with notable colleagues, including Yusheng Wu and Chengshan Niu. Their combined expertise enhances the research and development of effective pharmaceutical solutions.

Conclusion

Ruiyun Guo's contributions to the field of tyrosine kinase inhibition exemplify the importance of innovation in medical research. His patented work on bis-quinazoline derivatives showcases the potential for new treatments in combating cancer and other diseases.